CPT® Code 90389

1. Indications

The administration of Tetanus immune globulin (TIg) is indicated in specific clinical scenarios where immediate passive immunity against tetanus is required. The following conditions warrant the use of TIg:

• Post-exposure prophylaxis for individuals who have sustained a wound that may be contaminated with tetanus spores, particularly in those who are not fully immunized or whose vaccination status is uncertain.
• Prevention of tetanus in patients who have not received the appropriate tetanus vaccinations, especially in cases of deep puncture wounds or wounds with significant tissue damage.

2. Procedure

The procedure for administering Tetanus immune globulin (TIg) involves several key steps to ensure safe and effective delivery of the immunizing agent. Each step is critical for achieving the desired outcome of passive immunity against tetanus.

• Step 1: Patient Assessment - Prior to administration, a thorough assessment of the patient's immunization history and current health status is conducted. This includes determining if the patient has had previous tetanus vaccinations and evaluating the nature of the wound, if applicable.
• Step 2: Preparation of the Product - The TIg solution is prepared for administration. This involves checking the product for any signs of contamination or expiration and ensuring that it is at the appropriate temperature for injection.
• Step 3: Administration - The TIg is administered via intramuscular injection, typically into the deltoid muscle of the upper arm. The injection site is cleaned with an antiseptic to minimize the risk of infection. Care is taken to inject the solution slowly and steadily to ensure proper absorption.
• Step 4: Post-Administration Monitoring - After the injection, the patient is monitored for any immediate adverse reactions or side effects. This includes observing for signs of allergic reactions or discomfort at the injection site.

3. Post-Procedure

Following the administration of Tetanus immune globulin (TIg), patients are advised on post-procedure care and monitoring. It is important to inform patients about potential side effects, which may include localized pain, swelling, or redness at the injection site. Patients should be instructed to report any unusual symptoms or allergic reactions, such as difficulty breathing or hives, to their healthcare provider immediately. Additionally, the importance of following up with their primary care provider for any necessary vaccinations or further tetanus prophylaxis should be emphasized to ensure long-term protection against tetanus.